Concord Biotech to Trade Ex-Dividend Tomorrow for ₹10.70 Payout​

Ahmedabad, September 2, 2025 — Concord Biotech Limited (NSE: CONCORDBIO) will trade ex-dividend on Wednesday, September 3, 2025, for a dividend of ₹10.70 per share on a face value of ₹1. The company has fixed the same date as the record date to determine shareholder eligibility for the payout.

Dividend Details

The company has announced a dividend of ₹10.70 per share, with a face value of ₹1, both the ex-dividend date and record date are for September 3, 2025. This payout is an increase from the previous dividend of ₹8.75 per share declared in June 2024. Increasing is an important acknowledgement of the company’s intention to reward shareholders consistently and to indicate that it continues to enjoy a solid financial position and strong business performance. Whoever is on record as of this date will be entitled to receive this improved dividend.

Dividend History

The dividend history of the company exhibits growth in the payout to shareholders. It has announced it will pay ₹10.70 per share in 2025, and the ex-dividend and record date is set to September 3, 2025. In 2024, shareholders were paid dividends of ₹8.75 per share, with an ex-dividend date of June 21 and a record date of June 22.

Share Market Snapshot

On 2 September 2025, the share price of the company closed at ₹1,687.50, up ₹1.60 (0.095%) from its previous close of ₹1685.90. The hare opened at ₹1,714.00 and traded between ₹1,714.00 and ₹1,670.10, reaching its high and low. The P/E ratio remained at 42.47, compared with a market cap of 17.80KCr.

Concord Biotech Limited is a fully integrated biopharma company engaged in the development, manufacturing, and marketing of fermentation-based active pharmaceutical ingredients (APIs) across immunosuppressants and oncology segments. The company is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE).

REF: https://www.nseindia.com/get-quotes/equity?symbol=CONCORDBIO

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations